Edition:
United Kingdom

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,450.00GBp
18 Feb 2019
Change (% chg)

-- (--)
Prev Close
1,450.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,575,742
52-wk High
1,548.50
52-wk Low
1,242.50

Select another date:

Sat, Feb 9 2019

Smith & Nephew in talks to buy NuVasive for over $3 billion - FT

Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion (£2.3 billion), the Financial Times reported on Friday, citing people familiar with the talks.

Smith & Nephew in talks to buy NuVasive for over $3 billion: FT

Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

UPDATE 2-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

UPDATE 1-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

Emerging markets to fuel Smith & Nephew revenue growth in 2019

British medical products maker Smith & Nephew forecast full-year revenue growth in line with analysts' expectations on Thursday, as it looks to grow in emerging markets and expand its product line-up.

CORRECTED-UPDATE 1-Emerging markets to fuel Smith & Nephew revenue growth in 2019

Feb 7 British medical products maker Smith & Nephew forecast full-year revenue growth in line with analysts' expectations on Thursday, as it looks to grow in emerging markets and expand its product line-up.

Smith & Nephew misses on Q4 revenue as developed markets slow

Feb 7 British medical products maker Smith & Nephew fell short of analysts' expectations for fourth-quarter revenue on Thursday, as growth in established markets including the United States slowed and the company was hurt by a stronger dollar.

U.S. FDA removes safety warning from Smith & Nephew's diabetic gel

British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.

U.S. FDA removes safety warning from Smith & Nephew's diabetic gel

Dec 5 British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.

Select another date: